Contact Us
Contact Us
Contact Us

Popular Keywords

Categories

No Record Found

View All Results

REGALA, Eugenio Emmanuel V.

REGALA, Eugenio Emmanuel V.

Dr. Eugenio Emmanuel V. Regala is a medical oncologist who practices in UST Hospital, The Medical City, And Diliman Doctors Hospital. He completed his residency training for internal medicine at the University of Santo Tomas Hospital and also completed fellowship training in medical oncology at the same institution.  He is currently the assistant chief of the section of the Department of Internal Medicine, Section of Medical Oncology in UST Hospital. He is also a UST Faculty of Medicine and Surgery associate professor. He is active in the field of research and is the principal investigator of multiple clinical trials recognized internationally. He has also published multiple journals on breast, lung, head and neck, and hepatocellular cancers.

Updates

UST recognizes research achievements of faculty

UST recognizes research achievements of faculty

A total of 121 faculty members were recognized in the…

Read more
More Updates

Assoc. Prof. Eugenio Emmanuel V. Regala, MD, FPCP, FPSMO

Department of Medicine | Faculty of Medicine and Surgery

evregala@ust.edu.ph

Academic Qualifications

Research Highlights

Research Interests

Academic Qualifications

Degrees

  • Doctor of Medicine, University of Santo Tomas – Manila, Philippines, 1990-1994
  • Bachelor of Science in Zoology, University of Santo Tomas – Manila, Philippines, 1986-1990

Eligibility

  • Professional Regulation Commission Physician Licensure Examination

Postgraduate Trainings  

  • Fellowship in Medical Oncology, University of Santo Tomas Hospital – Manila, Philippines, 2001-2004
  • Residency in Internal Medicine, University of Santo Tomas Hospital – Manila, Philippines, 1998-2000
  • Post-Graduate Internship, St. Luke’s Medical Center, 1994-1995 

Research Highlights

  • Principal Investigator in multiple International Clinical Trials involving Lung, Head and Neck, Hepatocellular Cancers Published journals recognized internationally: (2017) Evidence on Effectiveness of Weekly vs. Tri-weekly Cisplatin Concurrent with Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Published: British Journal of Radiology (2001) Peritonitis among Patients on Intermittent Peritoneal Dialysis: A Three Year Experience at UST Hospital. Published: Philippine Journal of Internal Medicine (Jan-Feb. 2001 Volume 39 No.1)

Research Interests

  • Breast, Lung, Head and neck and hepatocellular cancers

Courses Handled

Major Recognitions

Professional Activities

Courses Handled

  • Medicine 1 – Physical Diagnosis (2nd year Medical Students)
  • Medicine 2 (3rd year Medical Students)
  • Medicine 3 – Clerkship (4th year Medical Students) 

Major Recognitions

  

Professional Activities

Academic Appointment 

  • Associate Professor 5, Department of Medicine, UST Faculty of Medicine & Surgery 

 Administrative Appointments/Positions 

  • Chief, Section of Medical Oncology/Hematology, Department of Medicine, UST Faculty of Medicine and Surgery 
  • Assistant Chief, Section of Medical Oncology, Department of Medicine, UST Faculty of Medicine and Surgery 
  • Head, Medical Oncology Unit, Benavides Cancer Institute, University of Santo Tomas Hospital

Past Positions

  • Training Officer, Medical Oncology, University of Santo Tomas Hospital, 2009-2020 
  • Member, Philippine Specialty Board of Medical Oncology, 2009-2013
  • Head, Internship Program, University of Santo Tomas Hospital, Department of Medicine, 2009-2011
  • Member, Scientific Committee, 41st Annual Convention Philippine College of Physicians, 2011

Professional Affiliations

  • Fellow, Philippine College of Physicians
  • Fellow, Philippine Society of Medical Oncology
  • Member, American Society of Clinical Oncology, 2014
  • Member, International Association for the Study of Lung Cancer, 2013
  • Member, European Society of Medical Oncology, 2006
  • Member, University of Santo Tomas Medical Alumni Association, 2002
  • Member, Filipino-Chinese Medical Society, 2002

Hospital Affiliations 

  • The Medical City
  • University of Santo Tomas Hospital

Selected Publications

Selected Publications

  • 2017 Co-Author, Evidence on Effectiveness of Weekly vs. Tri-weekly Cisplatin Concurrent with Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Published: British Journal of Radiology
  • 2004 Author, Quality of Life Among Breast Cancer Patients Treated in the Adjuvant and Metastatic Setting
  • 2002 Author, Clinical Characteristics of Lung Cancer Patients at UST Hospital: A Three-Year Experience
  • 2001 Co-Author, Pulmonary Blastoma in a 22-Year-Old Male: A Case Report
  • 2000 Author, Peritonitis among Patients on Intermittent Peritoneal Dialysis: A Three Year Experience at UST Hospital. Published: Philippine Journal of Internal Medicine (Jan-Feb. 2001 Volume 39 No.1)
  • 1999 Author, Single E Test in the Assessment of Asthmatic Patients in Exacerbation. Published: Santo Tomas Journal of Medicine
  • 1998 Author, Pulmonary Lymphangioleiomyomatosis in a Pregnant Patient: A Case Report Poster Presentation at 19th Asian Pacific Congress on Diseases of the Chest
  • Clinical Trials: Principal Investigator 2019, A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III Non-small Cell Lung Cancer (AEGEAN Study)
  • Principal Investigator 2015, A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Sub Investigator 2014, A Phase III Randomized, Double-Blind Study of PF-05280014 plus Paclitaxel versus Trastuzumab plus Paclitaxel for the First-Line Treatment of Patients with HER-2 Positive Metastatic Breast Cancer
  • Principal Investigator 2010, A Phase 1b/2 study of AV299 (formerly SCH 900105) in Combination with Gefitinib in Asian subjects with Non-Small Cell Lung Cancer
  • Principal Investigator 2010, Study in Asian Patients with Advanced NSCLC of Adenocarcinoma Histology to Assess EGFR Mutation Status
  • Principal Investigator 2009, A Multinational, Randomized, Open Label, Phase III Study of Sunitinib Malate versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
  • Principal Investigator 2010, A Randomized Placebo-Controlled Trial of the Efficacy and Tolerability of Flexibly Dosed Pregabalin in the Treatment of Cancer-Induced Bone Pain
  • Sub Investigator 2008, A Randomized Multi-Center Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 Over Expressing Inflammatory Breast Cancer
  • Sub Investigator 2001, Gefitinib Versus Best Supportive Care in Previously Treated Locally Advanced and Metastatic Non-Small Cell Lung Cancer